NovoCure
NVCR
NVCR
78 hedge funds and large institutions have $166M invested in NovoCure in 2016 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 29 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
24% more funds holding
Funds holding: 63 → 78 (+15)
3% more capital invested
Capital invested by funds: $161M → $166M (+$5.14M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
78
Holding in Top 10
2
Calls
$4.49M
Puts
$248K
Top Buyers
| 1 | +$11.1M | |
| 2 | +$1.51M | |
| 3 | +$1.22M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$869K |
| 5 |
Goldman Sachs
New York
|
+$609K |
Top Sellers
| 1 | -$1.82M | |
| 2 | -$1.34M | |
| 3 | -$543K | |
| 4 |
PCM
Prelude Capital Management
New York
|
-$337K |
| 5 |
CCM
Century Capital Management
Boston,
Massachusetts
|
-$251K |